Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment

NCT00978224 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT00978224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00978224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment
Lead sponsor
Catalysis SL
Phase
Phase 3
Overall status
Suspended
Start date
October 31, 2009
Completion date
September 30, 2011
Enrollment
152 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory syndrome